Delivery Order SPE2DB22D3009-SPE2DB24FAS40
Award Date
3/19/24
Potential Completion Date
3/20/24
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract, valued at $48,794.65, is for the delivery of 4,564,017,028 units of bupropion hydrochloride extended-release tablets (300 mg) over a period ending on March 20, 2024. AmerisourceBergen Drug Corp is a subsidiary of AmerisourceBergen Corporation and serves as a prime contractor...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,563,337,776 units of the prescription drug Bupropion HCL XL 300 mg tablets. The delivery order has a firm fixed price of $60,566.68 and an ultimate completion date of January 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $51,106.26, is for the delivery of bupropion hydrochloride extended-release 300 mg tablets. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The delivery order, valued at $12,723.06, is for the supply of 4,564,083,598 units of Bupropion HCL XL 150 mg tablets to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order falls under a larger indefinite delivery contract (IDC) awarded...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The $1,370.20 award is for the delivery of 4,564,253,884 units of Bupropion HCL XL 300 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,042,870 units of Bupropion HCL XL 300 mg tablets. The order, valued at $39,859.71, has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $1,814.29, is for the supply of Bupropion HCL XL 300 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,981,495 units of Bupropion HCl XL 300 mg tablets. The $3,363.79 contract has a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,082.02, is for the provision of bupropion hydrochloride extended-release tablets (300 mg, 90-count). The contract has a period of performance through May 8, 2024 and does not have a set-aside designation, indicating it was competitively awarded....
This $25,422.59 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The order is for the supply of 4,564,544,823 tablets of Bupropion HCL XL 300 mg, a prescription medication, with a performance period ending on May 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to...